A Cell-based Model of Endothelial Cell Migration, Proliferation and Maturation During Corneal Angiogenesis

The motivation of this work stems from two critical experimental observations associated with corneal angiogenesis: (1) angiogenesis will not succeed without endothelial cell proliferation, and (2) proliferation mainly occurs at the leading edge of developing sprouts (Sholley et al., Lab. Invest. 51:624–634, 1984). To discover the underlying mechanisms of these phenomena, we develop a cell-based mathematical model that integrates a mechanical model of elongation with a biochemical model of cell phenotype variation regulated by angiopoietins within a developing sprout. This model allows for a detailed study of the relative roles of endothelial cell migration, proliferation, and maturation. The model is validated by quantitatively comparing its predictions with data derived from corneal angiogenesis experiments. We conclude that cell elasticity and cell-to-cell adhesion allow only limited sprout extension in the absence of proliferation, and the maturation process combined with bioavailability of VEGF can explain the localization of proliferation to the leading edge. We also use this model to investigate the effects of X-ray irradiation, Ang-2 inhibition, and extracellular matrix anisotropy on sprout morphology and extension.

[1]  Harsh V Jain,et al.  Modeling the VEGF–Bcl-2–CXCL8 Pathway in Intratumoral Agiogenesis , 2008, Bulletin of mathematical biology.

[2]  Yi Jiang,et al.  A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. , 2007, Biophysical journal.

[3]  H. Augustin,et al.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004, Blood.

[4]  H. Levine,et al.  Angiogenesis-A Biochemical/Mathematical Perspective , 2006 .

[5]  F. M. Gabhann,et al.  receptors on endothelial cells growth factor and placental growth factor to VEGF Model of competitive binding of vascular endothelial , 2005 .

[6]  Michael Bergdorf,et al.  A hybrid model for three-dimensional simulations of sprouting angiogenesis. , 2008, Biophysical journal.

[7]  Z. Agur,et al.  A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth , 2004, Angiogenesis.

[8]  D. Balding,et al.  A mathematical model of tumour-induced capillary growth. , 1985, Journal of theoretical biology.

[9]  H. Augustin,et al.  The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism , 2005, Journal of Cell Science.

[10]  D. Pode,et al.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.

[11]  K. Peters,et al.  Proteome analysis of the rat cornea during angiogenesis , 2003, Proteomics.

[12]  H M Byrne,et al.  On the rôle of angiogenesis in wound healing , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[13]  Jonathan A. Sherratt,et al.  Models of epidermal wound healing , 1990, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[14]  Hans G. Othmer,et al.  A continuum model of motility in ameboid cells , 2004, Bulletin of mathematical biology.

[15]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[16]  M. Plank,et al.  A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins. , 2004, Journal of theoretical biology.

[17]  Aleksander S. Popel,et al.  Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting , 2009, BMC Systems Biology.

[18]  R T Tranquillo,et al.  A methodology for the systematic and quantitative study of cell contact guidance in oriented collagen gels. Correlation of fibroblast orientation and gel birefringence. , 1993, Journal of cell science.

[19]  D. Lauffenburger,et al.  Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. , 2005, Experimental cell research.

[20]  N Paweletz,et al.  Tumor-related angiogenesis. , 1989, Critical reviews in oncology/hematology.

[21]  B. Sleeman,et al.  Mathematical modeling of the onset of capillary formation initiating angiogenesis , 2001, Journal of mathematical biology.

[22]  Ferguson Gp,et al.  Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. , 1984 .

[23]  T. Skalak,et al.  The FASEB Journal express article 10.1096/fj.03-0933fje. Published online February 6, 2004. Multicellular simulation predicts microvascular patterning and in silico tissue assembly , 2022 .

[24]  A. Cho,et al.  Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. , 1997, Circulation research.

[25]  F. Yuan,et al.  Numerical simulations of angiogenesis in the cornea. , 2001, Microvascular research.

[26]  J. Isner,et al.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.

[27]  M J Plank,et al.  A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies. , 2003, Mathematical medicine and biology : a journal of the IMA.

[28]  Kamila Larripa,et al.  Transport of a 1D viscoelastic actin-myosin strip of gel as a model of a crawling cell. , 2006, Physica A.

[29]  Peter Carmeliet,et al.  Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[30]  B. Sleeman,et al.  Tumour induced angiogenesis as a reinforced random walk: Modelling capillary network formation without endothelial cell proliferation , 2002 .

[31]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[32]  U. Schlötzer-Schrehardt,et al.  Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation , 2003, The British journal of ophthalmology.

[33]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[34]  H M Byrne,et al.  A model of wound-healing angiogenesis in soft tissue. , 1996, Mathematical biosciences.

[35]  M. Dembo,et al.  Traction force microscopy of migrating normal and H-ras transformed 3T3 fibroblasts. , 2001, Biophysical journal.

[36]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[37]  Thomas Hartmann,et al.  Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. , 2004, Cancer cell.

[38]  M. Chaplain,et al.  Continuous and discrete mathematical models of tumor-induced angiogenesis , 1998, Bulletin of mathematical biology.

[39]  Gerald Kaiser Wavelet Filtering with the Mellin Transform , 1996 .

[40]  H. Othmer,et al.  Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.

[41]  Leah Edelstein-Keshet,et al.  Mathematical models in biology , 2005, Classics in applied mathematics.

[42]  P K Maini,et al.  A simple mechanistic model of sprout spacing in tumour-associated angiogenesis. , 2008, Journal of theoretical biology.

[43]  Michael Simons,et al.  Branching morphogenesis. , 2008, Circulation research.

[44]  Shuyu Sun,et al.  A deterministic model of growth factor-induced angiogenesis , 2005, Bulletin of mathematical biology.

[45]  D A Lauffenburger,et al.  Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. , 1991, Journal of theoretical biology.

[46]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[47]  T. Acker,et al.  Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. , 2000, The American journal of pathology.

[48]  A Jamie,et al.  Branching Morphogenesis , 2004 .

[49]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[50]  L. Preziosi,et al.  Modeling the early stages of vascular network assembly , 2003, The EMBO journal.

[51]  F. Yuan,et al.  Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: II. Numerical simulations. , 2008, Microvascular research.

[52]  H. Dvorak,et al.  Stable Expression of Angiopoietin-1 and Other Markers by Cultured Pericytes: Phenotypic Similarities to a Subpopulation of Cells in Maturing Vessels During Later Stages of Angiogenesis In Vivo , 2002, Laboratory Investigation.

[53]  O. Thoumine,et al.  Time scale dependent viscoelastic and contractile regimes in fibroblasts probed by microplate manipulation. , 1997, Journal of cell science.

[54]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[55]  Alexander R. A. Anderson,et al.  A Mathematical Model for Capillary Network Formation in the Absence of Endothelial Cell Proliferation , 1998 .

[56]  G. Yancopoulos,et al.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.

[57]  J. Isner,et al.  Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* , 1998, The Journal of Biological Chemistry.

[58]  I. Weissman,et al.  Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.

[59]  Robert S Warren,et al.  Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[60]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[61]  T. Pollard,et al.  Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.

[62]  A. Adamis,et al.  Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. , 1998, Investigative ophthalmology & visual science.

[63]  M. Chaplain Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development , 1996 .

[64]  Manfred Radmacher,et al.  Direct measurement of the lamellipodial protrusive force in a migrating cell , 2006, The Journal of cell biology.

[65]  K. Costa,et al.  Non-Hertzian approach to analyzing mechanical properties of endothelial cells probed by atomic force microscopy. , 2006, Journal of biomechanical engineering.

[66]  M. Hartnett,et al.  Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. , 2007, Blood.

[67]  Hans G. Othmer,et al.  Aggregation, Blowup, and Collapse: The ABC's of Taxis in Reinforced Random Walks , 1997, SIAM J. Appl. Math..

[68]  J. Wilson,et al.  Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[69]  B. Sleeman,et al.  Mathematical modeling of capillary formation and development in tumor angiogenesis: Penetration into the stroma , 2001, Bulletin of mathematical biology.

[70]  Shaomeng Wang,et al.  Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. , 2005, Cancer research.

[71]  Y. Kanai,et al.  Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis , 2006, Laboratory Investigation.

[72]  Andras Czirok,et al.  Network formation of tissue cells via preferential attraction to elongated structures. , 2006, Physical review letters.

[73]  Salvatore Torquato,et al.  Modeling the effects of vasculature evolution on early brain tumor growth. , 2006, Journal of theoretical biology.

[74]  M. Chaplain,et al.  Explicit solutions of a simplified model of capillary sprout growth during tumor angiogenesis , 1995 .

[75]  T. Chan‐Ling Glial, vascular, and neuronal cytogenesis in whole‐mounted cat retina , 1997, Microscopy research and technique.

[76]  Avner Friedman,et al.  Tutorials in Mathematical Biosciences III , 2005 .

[77]  M. Plank,et al.  Lattice and non-lattice models of tumour angiogenesis , 2004, Bulletin of mathematical biology.

[78]  H. M. Byrne,et al.  Mathematical models for tumour angiogenesis: Numerical simulations and nonlinear wave solutions , 1995 .

[79]  Panayotis G. Kevrekidis,et al.  A hybrid model for tumor-induced angiogenesis in the cornea in the presence of inhibitors , 2007, Math. Comput. Model..

[80]  Avner Friedman,et al.  Wound angiogenesis as a function of tissue oxygen tension: A mathematical model , 2008, Proceedings of the National Academy of Sciences.

[81]  Gavin Thurston,et al.  Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.

[82]  Siqing Shan,et al.  Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Joseph B. Kearney,et al.  The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. , 2004, Blood.